High prevalence of extended-spectrum β-lactamase-producing pathogens: Results of a surveillance study in two hospitals in Ujjain, India

Infection and Drug Resistance

Volumn 5, Issue 1, 2012, Pages 65-73

  Pathak, Ashish ^a,b   Marothi, Yogyata ^b   Kekre, Vandana ^b   Mahadik, Kalpana ^b   Macaden, Ragini ^c   Lundborg, Cecilia Stålsby ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

^b RD Gardi Medical College   (India)

^c ST JOHN'S NATIONAL ACADEMY OF HEALTH SCIENCES   (India)

Author keywords

Antibiotic susceptibility; Extended spectrum lactamases; India; Surveillance

Indexed keywords

BETA LACTAM; CARBAPENEM; CEPHALOSPORIN; CIPROFLOXACIN; COTRIMOXAZOLE; EXTENDED SPECTRUM BETA LACTAMASE; LEVOFLOXACIN; QUINOLINE DERIVED ANTIINFECTIVE AGENT;

ADULT; AGED; ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL PNEUMONIA; BACTERIAL VIRULENCE; BACTERIUM ISOLATION; BLOODSTREAM INFECTION; CONTROLLED STUDY; DISEASE SURVEILLANCE; DISK DIFFUSION; ESCHERICHIA COLI; EXTENDED SPECTRUM BETA LACTAMASE PRODUCING ENTEROBACTERIACEAE; FEMALE; HUMAN; INDIA; INFANT; KLEBSIELLA PNEUMONIAE; MAJOR CLINICAL STUDY; MALE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MICROBIAL SENSITIVITY TEST; NONHUMAN; PREVALENCE; PROSPECTIVE STUDY; PSEUDOMONAS AERUGINOSA; SALMONELLA TYPHI; STAPHYLOCOCCUS AUREUS; URINARY TRACT INFECTION; VAGINITIS;

EID: 84861396719     PISSN: 11786973     EISSN: None     Source Type: Journal    
DOI: 10.2147/idr.s30043     Document Type: Article

References (30)

1. World Health Organisation. Improving the containment of antimicrobial resistance. Geneva, Switzerland: World Health Organisation; 2005. Available from: http://www.searo.who.int/LinkFiles/BCT_Regional_Strategy_ARM_ver31032010.pdf. Accessed March 5, 2012.
2. Cars O, Hogberg LD, Murray M, et al. Meeting the challenge of antibiotic resistance. Br Med J. 2008;337:a1438.
3. Goossens H, Ferech M, Vander Stichele R, Elseviers M. Outpatient antibiotic use in Europe and association with resistance: a cross-national database study. Lancet. 2005;365(9459):579-587.
4. Alvan G, Edlund C, Heddini A. The global need for effective antibiotics- a summary of plenary presentations. Drug Resist Updat. 2011;14(2):70-76.
5. Carlet J, Collignon P, Goldmann D, et al. Society's failure to protect a precious resource: antibiotics. Lancet. 2011;378(9788):369-371.
6. Kumarasamy KK, Toleman MA, Walsh TR, et al. Emergence of a new antibiotic resistance mechanism in India, Pakistan, and the UK: a molecular, biological, and epidemiological study. Lancet Infect Dis. 2010;10(9):597-602.
7. Kamat VR, Nichter M. Pharmacies, self-medication and pharmaceutical marketing in Bombay, India. Soc Sci Med. 1998;47(6):779-794.
8. Lakshmi V. Need for national/regional guidelines and policies in India to combat antibiotic resistance. Indian J Med Microbiol. 2008;26(2):105-107.
9. Sahoo KC, Tamhankar AJ, Johansson E, Lundborg CS. Antibiotic use, resistance development and environmental factors: a qualitative study among healthcare professionals in Orissa, India. BMC Public Health. 2010;10:629.
10. Shanmugam S. Save antibiotics for future of mankind. J Assoc Physicians India. 2011;59:64-65.
11. Subbalaxmi MV, Lakshmi V, Lavanya V. Antibiotic resistance - experience in a tertiary care hospital in south India. J Assoc Physicians India. 2010;58 Suppl:18-22.
12. Varghese GK, Mukhopadhya C, Bairy I, Vandana KE, Varma M. Bacterial organisms and antimicrobial resistance patterns. J Assoc Physicians India. 2010;58 Suppl:23-24.
13. Murray PR BE, Pfaller MA, Tenover FC, Yolken RH. Manual of Clinical Microbiology. 7th ed. Washington, DC: ASM Press; 1999.
14. Clinical Laboratory Standards Institute. Performance Standards for Antimicrobial Disk Susceptibility Tests. Approved standard, 9th ed. CLSI document M2-A9. Wayne, PA: Clinical Laboratory Standards Institute; 2006.
15. Jarlier V, Nicolas MH, Fournier G, Philippon A. Extended broadspectrum beta-lactamases conferring transferable resistance to newer beta-lactam agents in Enterobacteriaceae: hospital prevalence and susceptibility patterns. Rev Infect Dis. 1988;10(4):867-878.
16. Magiorakos AP, Srinivasan A, Carey RB, et al. Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance. Clin Microbiol Infect. 2012;18(3):268-281.
17. Ashley EA, Lubell Y, White NJ, Turner P. Antimicrobial susceptibility of bacterial isolates from community acquired infections in Sub-Saharan Africa and Asian low and middle income countries. Trop Med Int Health. 2011;16(9):1167-1179.
18. Jean SS, Hsueh PR. High burden of antimicrobial resistance in Asia. Int J Antimicrob Agents. 2011;37(4):291-295.
19. Bell JM, Chitsaz M, Turnidge JD, Barton M, Walters LJ, Jones RN. Prevalence and signif icance of a negative extended-spectrum beta-lactamase (ESBL) confirmation test result after a positive ESBL screening test result for isolates of Escherichia coli and Klebsiella pneumoniae: results from the SENTRY Asia-Pacific Surveillance Program. J Clin Microbiol. 2007;45(5):1478-1482.
20. Biedenbach DJ, Bell JM, Sader HS, Fritsche TR, Jones RN, Turnidge JD. Antimicrobial susceptibility of Gram-positive bacterial isolates from the Asia-Pacific region and an in vitro evaluation of the bactericidal activity of daptomycin, vancomycin, and teicoplanin: a SENTRY Program Report (2003-2004). Int J Antimicrob Agents. 2007;30(2): 143-149.
21. Rosenthal VD, Bijie H, Maki DG, et al. International Nosocomial Infection Control Consortium (INICC) report, data summary of 36 countries, for 2004-2009. Am J Infect Control. September 10, 2011. [Epub ahead of print.]
22. Bhattacharya S. Is screening patients for antibiotic-resistant bacteria justified in the Indian context? Indian J Med Microbiol. 2011;29(3):213-217.
23. Mayank D, Anshuman M, Singh RK, Afzal A, Baronia AK, Prasad KN. Nosocomial cross-transmission of Pseudomonas aeruginosa between patients in a tertiary intensive care unit. Indian J Pathol Microbiol. 2009;52(4):509-513.
24. El Solh AA, Alhajhusain A. Update on the treatment of Pseudomonas aeruginosa pneumonia. J Antimicrob Chemother. 2009;64(2):229-238.
25. Zaki SA, Karande S. Multidrug-resistant typhoid fever: a review. J Infect Dev Ctries. 2011;5(5):324-337.
26. Mehnert-Kay SA. Diagnosis and management of uncomplicated urinary tract infections. Am Fam Physician. 2005;72(3):451-456.
27. Eshwarappa M, Dosegowda R, Aprameya IV, Khan MW, Kumar PS, Kempegowda P. Clinico-microbiological profile of urinary tract infection in south India. Indian J Nephrol. 2011;21(1):30-36.
28. Pathak A, Mahadik K, Dhaneria SP, Sharma A, Eriksson B, Lundborg CS. Antibiotic prescribing in outpatients: Hospital and seasonal variations in Ujjain, India. Scand J Infect Dis. 2011;43(6-7):479-488.
29. Castanheira M, Deshpande LM, Mathai D, Bell JM, Jones RN, Mendes RE. Early dissemination of NDM-1- and OXA-181-producing Enterobacteriaceae in Indian hospitals: report from the SENTRY Antimicrobial Surveillance Program, 2006-2007. Antimicrob Agents Chemother. 2011;55(3):1274-1278.
30. Asensio A, Alvarez-Espejo T, Fernandez-Crehuet J, et al. Trends in yearly prevalence of third-generation cephalosporin and fluoroquinolone resistant Enterobacteriaceae infections and antimicrobial use in Spanish hospitals, Spain, 1999 to 2010. Euro Surveill. 2011;16(40): pii 19983.